Drugs / pWRG/VEE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01984983 | Dec 2013 → Jun 2014 | Venezuelan equine encephalitis | Ichor Medical Systems Incorporated | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pWRG/VEE | “We developed a candidate DNA vaccine expressing the E3-E2-6K-E1 genes of VEEV (pWRG/VEE) and performed a Phase 1 clinical study” PMID 27206386 ↗ May 2016 |
| Modality | Vaccine | “We developed a candidate DNA vaccine expressing the E3-E2-6K-E1 genes of VEEV (pWRG/VEE) and performed a Phase 1 clinical study” PMID 27206386 ↗ May 2016 |
| Route | Intramuscular | “administered by intramuscular (IM) or intradermal (ID) electroporation (EP)” PMID 27206386 ↗ May 2016 |